摘要
高血压是常见的心血管疾病之一,它在动脉粥样硬化(As)的发生、发展过程中扮演了重要角色,且易并发微量白蛋白尿。同时,高血压患者的微量白蛋白尿与As、靶器官血管损害、心血管事件的发生密切相关。通过对高血压患者行微量白蛋白尿水平检测,可在一定程度上早期预测As的发生,从而有助于更好地管理高血压患者。而早期采取适当措施,对于高血压As患者的病情评估、治疗及改善预后有较高的临床应用价值。
Hypertension is one of the most common cardiovascular diseases, which plays a significant role in the occurrence and development of atherosclerosis (As), often accompanying with microalbuminuria. Meanwhile, microalbuminuria is closely related As, target-organ damage, and cardiovascular events in patients with hypertension. By detecting the level of microalbuminuria in patients with hypertension,it is helpful to predict the occurrence of As to some extent and for the management of hypertension. Early treatment to microalbuminuria has a high clinical application value for the disease evaluation ,treatment and improvement of prognosis of hypertensive patients with As.
作者
李驹
郝应禄
李燕萍
LI Ju HAO Yinglu LI Yanping.(Department of Cardiology, Yunnan Province Yuxi City People's Hospital, Yuxi 653100, China)
出处
《医学综述》
2017年第8期1510-1514,共5页
Medical Recapitulate